Skip to content

CCIA 5th Annual Policy Conference Speakers

Featured Speakers

Gavin official

Gavin Newsom

Governor, California

Gavin Newsom
Governor, California


Newsom is widely recognized for his willingness to lead – repeatedly developing, advocating, and implementing innovative and groundbreaking solutions to some of our most challenging issues. On a wide range of topics including same-sex marriage, gun safety, marijuana, the death penalty, universal health care, access to preschool, technology, criminal justice reform, and the minimum wage, Newsom stuck his neck out and did the right thing, which often led to sweeping changes when his policies were ultimately accepted, embraced, and replicated across the state and nation.

Newsom’s top priorities for his administration are tackling our state’s affordability crisis, creating inclusive economic growth and opportunity for every child, and standing up for California values — from civil rights, to immigration, environmental protection, access to quality schools at all levels, and justice.

Governor Newsom is married to Jennifer Siebel Newsom. They have four children: Montana, Hunter, Brooklynn, and Dutch.
Web Logo Final
madam ambassador_3rd mech.indd

Eleni Kounalakis

Lt. Governor, California

Eleni Koualaski
Lieutenant Governor, California

Eleni Kounalakis is a California businesswoman, a wife and the mother of two teenage sons, and the former U.S. Ambassador to Hungary under President Barack Obama. Eleni was raised the proud daughter of an immigrant father who started out as a farmworker, and she believes in the values of hard work, education and political activism.

In 1992, Eleni started her career as a staff member of the California Democratic Party in Sacramento and worked in the historic election, which elected two women to the U.S. Senate and turned California blue.

After the election, Eleni joined her family business, AKT Development, one of California’s most respected housing development firms. Over the next 18 years, Eleni worked her way up from project manager to president. Her work delivering housing for middle-class families in the Sacramento region earned her recognition as one of Sacramento’s most prominent businesswomen.

In 2010, Eleni was appointed by President Barack Obama as the U.S. Ambassador to Hungary and served side-by-side President Obama and Secretary Hillary Clinton promoting democracy. She is the author of the highly acclaimed book, Madam Ambassador, Three Years of Diplomacy, Dinner Parties and Democracy in Budapest, published in 2015 by The New Press.

During her 18 years in the housing industry, Ambassador Kounalakis continued to work as a democratic activist, working on the campaigns of countless progressive candidates and initiatives. Passionate about early childhood development, she served on California’s First 5 Commission and the California Blue Ribbon Commission on Autism. She was appointed by Mayor Ed Lee to the San Francisco Port Commission, and currently chairs the California Advisory Council for International Trade and Investment.

Eleni Kounalakis graduated from Dartmouth College in 1989, and earned her MBA from UC Berkeley’s Haas School of Business in 1992. She also holds an Honorary Doctorate of Laws from the American College of Greece. She lives in San Francisco with her husband, veteran journalist Markos Kounalakis, and their two sons Neo and Eon.

Elected Officials

Bonta_headshot8

Assemblymember Rob Bonta

Assemblymember Rob Bonta

Assemblymember Rob Bonta was elected to the California State Assembly's 18th District in 2012, where he represents the cities of Oakland, Alameda, and San Leandro. He became the first Filipino American state legislator in California’s then 160-plus-year history.

Rob’s passion for opportunity and equality was instilled in him at a very young age by his parents, who taught him to understand injustice and the importance of joining the struggle to empower vulnerable and disadvantaged communities. His father was involved in the Civil Rights Movement, and stood with Dr. Martin Luther King, Jr. in the Deep South—marching for equality and justice in Selma. His mother was and continues to be a long-time leader in the Filipino social justice movement.

Growing up in a trailer a stone’s throw away from César Chávez’s home, Bonta watched closely as his parents worked for the United Farm Workers of America and organized Filipino and Mexican American farm workers, infusing his formative years with first-hand experience of one of the greatest peaceful social, racial, and economic justice movements of all time. This had a huge impact on Rob’s life choices and pursuits, inspiring his life’s commitment to helping people.

Rob believed legal training was one of the most powerful ways to effect positive change in the lives of those who needed it most. He worked his way through college cleaning laundry rooms and, with the help of financial aid, was able to achieve his dream of going to college and law school, obtaining his Juris Doctorate from Yale Law School after attending Yale College and Oxford University in England. Earning honors in college, Rob was also a scholar athlete, captaining the Yale Soccer team. He also paved the way for the advancement of students of color as a mentor and worked with children and families in nearby public housing neighborhoods.

His legal career included work as a Deputy City Attorney for the City and County of San Francisco, where he represented the City and County and its employees, and as a private attorney, where he fought to protect Californians from exploitation and racial profiling. Rob was undefeated at trial, never losing a jury verdict for his clients.

Rob began his career as a publicly-elected official at the local level, first as a Director of the Alameda Health Care District and later as Vice Mayor of the City of Alameda.

In the State Assembly, Bonta currently serves as the Assistant Majority Leader. He serves on the Appropriations, Communications and Conveyance, Governmental Organization, and Health Committees.

He has authored significant legislation that promotes and defends our California values of Justice, Inclusion, Equity and Opportunity.

The legislation includes:
The TRUTH Act, which stands up for, defends, and protects our immigrant neighbors. Signed into law in 2016, it requires immigrants be informed of their rights before speaking with ICE agents. It also mandates that local law enforcement hold a public forum to discuss their immigration policies, and makes all ICE-related records and data subject to the Public Records Act.

AB 72 from 2016 provides critical consumer protection from Surprise Medical Bills. A patient can receive a surprise bill even after they’ve done everything right and selected an in-network provider. Unbeknownst to the patient, a specialist who is not in his or her insurance’s network will provide treatment. The patient has no way of knowing that provider is out-of-network until a bill shows up. Ab 72 outlawed the practice of what the industry calls “balance billing” in these circumstances and now consumers who did everything right are protected from getting hit with a surprise bill.

AB 266, the Medical Cannabis Regulation & Safety Act, was a historic California cannabis policy bill. In 1996, California became the first state to legalize medical cannabis. But for almost 20 years, the legislature could not agree on a comprehensive set of regulations. Bonta, along with a bipartisan group of lawmakers, brought various stakeholders together to create a set of regulations that ensured patient and consumer safety, gave law enforcement foundational tools to fight impaired driving, protected children from cannabis marketing, and safeguarded the environment from harmful cultivation practices.

AB 1469 in 2014 ensured that California’s hard-working teachers receive the retirement benefits they’ve been promised. This bill tackled California’s largest unfunded liability head-on with a shared responsibility approach that created a permanent, on-going funding solution that will achieve full funding for teacher retirement.

The Buy Clean California Act, passed in 2017, was a first-of-its-kind environmental bill to fight climate change, the existential threat of our time, and close a large carbon loophole. With Buy Clean, California will put its money where its environmental values are and begin to purchase environmentally clean products for public building projects. This law was supported by a coalition of environmental, labor and industry groups-- all working together to protect our future, and our values and was recently featured during the Global Climate Action Summit in San Francisco in 2018.

In 2018, California passed historic bail reform, SB 10, to end an unfair, unsafe, predatory, for-profit money bail system and replace it with a system that’s safer and fairer. SB 10, which Bonta co-authored with his colleague Senator Bob Hertzberg, will implement a system based on an individual’s risk and not on their wealth. Justice should never favor the wealthy and punish the poor. But for too long, the California criminal justice system has treated people who are “guilty and rich” better than people who are “poor and innocent.” All Californians deserve justice and we should never have a justice system that is pay-to-play, a jail house door that opens and closes based on the size of one’s wallet instead of the size of one’s risk, or a practice that punishes poor people for being poor!

Rob and his wife Mialisa live in Alameda with their three children.
Low 29

Assemblymember Evan Low

Assemblymember Evan Low

Evan Low was elected to the California State Assembly in November 2014 to represent District 28. At the age of 31, Assemblymember Low became the youngest Asian American legislator to have been elected to the Assembly in state history. The district is located in Silicon Valley and includes Campbell, Cupertino, Los Gatos, Monte Sereno, Saratoga, and the areas of West San Jose, Willow Glen, Cambrian, and Almaden Valley in San Jose. Assemblymember Low chairs the Business and Professions Committee. In 2015, together with Assemblymember Ian Calderon (D-Whittier), he launched the first in the state California Legislative Technology & Innovation Caucus. The Caucus comprises of a bi-partisan group of Senators and Assemblymembers who view this as a statewide effort to ensure that California remains the global leader in technology and innovation.

Assemblymember Low is a lifelong resident of Silicon Valley and has been a regional community leader. His work within the community and deep knowledge of issues local residents faced led him to run for Campbell City Council in 2006. He made history as the first Asian American elected to Campbell's City Council.

In 2010, Assemblymember Low also made history by becoming the youngest openly LGBT mayor in the country at the age of 26. While serving on Campbell's City Council, he helped balance the city budget without eliminating vital services and increase government transparency by streaming City Council meetings online. Assemblymember Low promoted small business and job growth by cutting red tape and streamlining the licensing process for business owners.

Assemblymember Low has been named "Legislator of the Year" by the Internet Association, TechNet, The Computing Technology Industry Association, California Faculty Association, Cellular Telecommunications Industry Association, California District Attorneys Association and Faculty Association of California Community Colleges.

He also served as a community college instructor teaching American Government and Political Science at De Anza Community College.

A Bay Area native, Low attended local public schools and earned degrees from De Anza Community College and San Jose State University. He went on to graduate from the Senior Executives in State and Local Government Program at Harvard University.
unnamed 65

Senator Scott Weiner

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.

State Regulators

Lori Ajax is the first chief of the state's Bureau of Medical Marijuana Regulation.

Lori Ajax

Bureau Chief, BCC

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.
unnamed 65

Ricard Parrot, Director, CalCannabis Cultivation Licensing, CDFA

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.
unnamed 65

Ricard Parrot, Director, CalCannabis Cultivation Licensing, CDFA

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.
unnamed 65
Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.

Nicolas Maduros

Director, CDTFA

Industry Experts

websiteamyjenkins2

Amy Jenkins

Senior Policy Director, CCIA

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.
Lindsay 2018

Lindsay Robinson

Executive Director, CCIA

Lindsay Robinson
Executive Director, CCIA

Prior to becoming the Executive Director of the California Cannabis Industry Association, Lindsay was the Director of Development for the Marijuana Policy Project (MPP). Lindsay oversaw MPP’s national fundraising and membership strategies. Based in San Francisco, Lindsay was a key member of MPP’s fundraising team starting in 2010 and took the helm of the department in early 2014. MPP was responsible for passing adult use ballot initiatives in Nevada, Massachusetts, and Maine in 2016 while playing a supporting role in California with Prop 64. Lindsay’s team at MPP helped raise over $18 million for these campaigns in the 2016 election cycle.

She was one of the primary fundraisers for both Amendment 64, the 2012 ballot initiative to regulate cannabis like alcohol in Colorado, and Ballot Measure 2, a similar initiative that made cannabis legal in Alaska in 2014. Lindsay was elected to the Board of Directors for the California Cannabis Industry Association in January 2016 and served as the Chair of the Legislative Committee that same year.

Lindsay has been working to end cannabis prohibition for two decades, in both volunteer and professional capacities. Her passion for social justice has also led to more than 17 years in the nonprofit industry, fundraising for organizations like the SF-Marin Food Bank, the Center for Justice and Accountability, and La Raza Centro Legal. Lindsay received her undergraduate degree in Environmental Studies at the University of Vermont and has her Master’s in Nonprofit Administration from the University of San Francisco. She’s also a registered yoga instructor and tequila enthusiast, not necessarily in that order.
05_Saphria-Galoob

Saphira Galoob

Principal and CEO, The Liaison Group

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.
swetha headshot-2

Dr. Swetha Kaul

Cannalysis Labs

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.
unnamed 65

Elizabeth Ashford

EAZE

Dr. Swetha Kaul
CCIA Board Vice President

Dr. Swetha Kaul is an industry expert on cannabis laboratory testing and a passionate advocate for sensible regulations. She has over a decade of leadership and technical experience from academia, the pharmaceutical industry and the emerging field of cannabis testing. She has an MS in Pharmacology and Toxicology and a PhD in Analytical Chemistry from University of Kansas. Prior to joining the cannabis industry, Dr. Kaul worked at Allergan where she was responsible for leading drug development efforts including formulation research, stability studies, process development and CMC.

Her foray into cannabis began when she took on the role of Chief Scientific Officer at Cannalysis, a cannabis testing lab based in Santa Ana, California. At Cannalysis, she pioneered industry leading analytical techniques and standards for quality and compliance while guiding the lab through several successful audits and accreditations. Her ability to simplify scientific and regulatory concepts to a variety of audiences has made her an established presence at major events such as SXSW, MJBizCon, CCBC, CWCBExpo, Arcview, CCIA’s Policy Summit, Analytical Cannabis, Emerald Conference and Infused Products Conference. Dr. Kaul is recognized as a scientific authority in the cannabis community and has been featured by various media outlets such as NPR, CBS, and Spectrum News. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Dr. Kaul has participated in developing and promoting key legislative and regulatory policies. She is committed to legitimizing the cannabis industry through education and advocacy.
unnamed 65

Wesley Hein,

Mammoth Distribution

Lindsay Robinson
Executive Director, CCIA

Prior to becoming the Executive Director of the California Cannabis Industry Association, Lindsay was the Director of Development for the Marijuana Policy Project (MPP). Lindsay oversaw MPP’s national fundraising and membership strategies. Based in San Francisco, Lindsay was a key member of MPP’s fundraising team starting in 2010 and took the helm of the department in early 2014. MPP was responsible for passing adult use ballot initiatives in Nevada, Massachusetts, and Maine in 2016 while playing a supporting role in California with Prop 64. Lindsay’s team at MPP helped raise over $18 million for these campaigns in the 2016 election cycle.

She was one of the primary fundraisers for both Amendment 64, the 2012 ballot initiative to regulate cannabis like alcohol in Colorado, and Ballot Measure 2, a similar initiative that made cannabis legal in Alaska in 2014. Lindsay was elected to the Board of Directors for the California Cannabis Industry Association in January 2016 and served as the Chair of the Legislative Committee that same year.

Lindsay has been working to end cannabis prohibition for two decades, in both volunteer and professional capacities. Her passion for social justice has also led to more than 17 years in the nonprofit industry, fundraising for organizations like the SF-Marin Food Bank, the Center for Justice and Accountability, and La Raza Centro Legal. Lindsay received her undergraduate degree in Environmental Studies at the University of Vermont and has her Master’s in Nonprofit Administration from the University of San Francisco. She’s also a registered yoga instructor and tequila enthusiast, not necessarily in that order.
2018 Headshot (1)

Kimberly Simms

Law Offices of Kimberly Simms

Lindsay Robinson
Executive Director, CCIA

Prior to becoming the Executive Director of the California Cannabis Industry Association, Lindsay was the Director of Development for the Marijuana Policy Project (MPP). Lindsay oversaw MPP’s national fundraising and membership strategies. Based in San Francisco, Lindsay was a key member of MPP’s fundraising team starting in 2010 and took the helm of the department in early 2014. MPP was responsible for passing adult use ballot initiatives in Nevada, Massachusetts, and Maine in 2016 while playing a supporting role in California with Prop 64. Lindsay’s team at MPP helped raise over $18 million for these campaigns in the 2016 election cycle.

She was one of the primary fundraisers for both Amendment 64, the 2012 ballot initiative to regulate cannabis like alcohol in Colorado, and Ballot Measure 2, a similar initiative that made cannabis legal in Alaska in 2014. Lindsay was elected to the Board of Directors for the California Cannabis Industry Association in January 2016 and served as the Chair of the Legislative Committee that same year.

Lindsay has been working to end cannabis prohibition for two decades, in both volunteer and professional capacities. Her passion for social justice has also led to more than 17 years in the nonprofit industry, fundraising for organizations like the SF-Marin Food Bank, the Center for Justice and Accountability, and La Raza Centro Legal. Lindsay received her undergraduate degree in Environmental Studies at the University of Vermont and has her Master’s in Nonprofit Administration from the University of San Francisco. She’s also a registered yoga instructor and tequila enthusiast, not necessarily in that order.
unnamed 65

Darius Kemp

EAZE

Lindsay Robinson
Executive Director, CCIA

Prior to becoming the Executive Director of the California Cannabis Industry Association, Lindsay was the Director of Development for the Marijuana Policy Project (MPP). Lindsay oversaw MPP’s national fundraising and membership strategies. Based in San Francisco, Lindsay was a key member of MPP’s fundraising team starting in 2010 and took the helm of the department in early 2014. MPP was responsible for passing adult use ballot initiatives in Nevada, Massachusetts, and Maine in 2016 while playing a supporting role in California with Prop 64. Lindsay’s team at MPP helped raise over $18 million for these campaigns in the 2016 election cycle.

She was one of the primary fundraisers for both Amendment 64, the 2012 ballot initiative to regulate cannabis like alcohol in Colorado, and Ballot Measure 2, a similar initiative that made cannabis legal in Alaska in 2014. Lindsay was elected to the Board of Directors for the California Cannabis Industry Association in January 2016 and served as the Chair of the Legislative Committee that same year.

Lindsay has been working to end cannabis prohibition for two decades, in both volunteer and professional capacities. Her passion for social justice has also led to more than 17 years in the nonprofit industry, fundraising for organizations like the SF-Marin Food Bank, the Center for Justice and Accountability, and La Raza Centro Legal. Lindsay received her undergraduate degree in Environmental Studies at the University of Vermont and has her Master’s in Nonprofit Administration from the University of San Francisco. She’s also a registered yoga instructor and tequila enthusiast, not necessarily in that order.
Scroll To Top